Fundamentals of Transplant and Cellular Therapy-Day 2 - BiTE therapies - Enduring Material - Credit offering period June 16, 2026 - December 31, 2026
Sophia Marchinko PA-C
*Scientific basis/Immuno-effector cells
References:
NCCN Guidelines, JNCCN Consensus Recommendations, StatPearls
Target Audience
Physicians, nurses, pharmacists, and allied health care professionals who practice in hematological-medical units, skilled nursing facilities, home care, hospice, radiation oncology, surgical oncology, and/or cellular transplant.
Learning Objectives
Discuss the different types of BiTE Therapies
Evaluate the scientific basis of BiTE Therapy
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
Allegheny General Hospital designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Available Credit
- 0.25 AMA PRA Category 1 Credit™

Facebook
X
LinkedIn
Forward